No Data
No Data
Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million
Labcorp: Acquired Assets Currently Generate $85M-$100M Annual Revenue >LH OPK
Labcorp Holdings To Buy Select Assets of OPKO's BioReference Health Unit >LH OPK
Express News | Labcorp: Purchase Price for Transaction Is up to $225 Mln
Express News | Labcorp Announces Acquisition of Select Assets of Bioreference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Press Release: Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses